Finny discusses the unpredictable nature of clinical trials and the importance of skilled analysis in the investment process. He emphasizes the significance of identifying industries that not only promise long-term growth but also contribute positively to human flourishing. By focusing on sectors like orphan diseases and Alzheimer's, he highlights a philosophy of investing that aligns financial success with ethical responsibility.
